Contextualizing osteoarthritis care and the reasons for the gap between evidence and practice

Clinics in Geriatric Medicine

Volumn 26, Issue 3, 2010, Pages 419-431

  Dieppe, Paul ^a   Doherty, Michael ^b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Best practice; Contextual care; National Institute for Clinical Excellence; Osteoarthritis

Indexed keywords

CHLORIDE; CORTICOSTEROID; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; HEALTH CARE INDUSTRY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; INFORMATION DISSEMINATION; OSTEOARTHRITIS; PATIENT CARE; PHYSIOTHERAPY; PRACTICE GUIDELINE; REVIEW;

CONSENSUS; DELPHI TECHNIQUE; EVIDENCE-BASED MEDICINE; HUMANS; OSTEOARTHRITIS; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE;

EID: 77955500156     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2010.03.004     Document Type: Review

References (54)

1. Ayis S., Ebrahim S., Williams S., et al. Determinants of reduced walking speed in people with musculoskeletal pain. J Rheumatol 2007, 34:1905-1912.
2. Kadam U.T., Croft P.R. Clinical co-morbidity in osteoarthritis: associations with physical function in older patients in family practice. J Rheumatol 2007, 34:1899-1904.
3. Dieppe P.A., Lohmander S.L. Pathogenesis and management of pain in osteoarthritis. Lancet 2005, 365:965-973.
4. Juni P., Reichenbach S., Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 2006, 20:721-740.
5. Neame R., Doherty M. Managing osteoarthritis. Practitioner 2003, 247:775-779.
6. Zhang W., Moskowitz R.W., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007, 15:981-1000.
7. Zhang W., Moskowitz R.W., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162.
8. Jordan K.M., Arden N., Doherty M., et al. EULAR Recommendations: an evidence based medicine approach to the management of knee osteoarthritis. Report of a Task Force of the Standing Committee of Clinical Trials and International Studies. Ann Rheum Dis 2003, 62:1145-1155.
9. Zhang W., Doherty M., Arden N., et al. EULAR recommendations: an evidence based medicine approach to the management of hip osteoarthritis. Report of a Task Force of the Standing Committee of Clinical Trials and International Studies. Ann Rheum Dis 2005, 64:669-681.
10. Zhang W., Doherty M., Leeb B.F., et al. EULAR evidence-based recommendations for the management of hand osteoarthritis. Report of a Task Force of the EULAR Standing Committee of Clinical Trials and International Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:377-388.
11. s Osteoarthritis - national clinical guideline for care and management in adults 2008. Available at:, Accessed March 30, 2010. http://guidance.nice.org.uk/CG59.
12. Altman R.D., Hochberg M.C., Moskowitz R.W., et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000, 43(9):1905-1915.
13. Roddy E., Doherty M. Differences between the ACR and EULAR guidelines on management of knee osteoarthritis. Rheum Dis Clin North Am 2003, 29:717-731.
14. Sackett D.L., Rosenberg W.M.C., Gray J.A.M., et al. Evidence based medicine: what it is and what it isn't. BMJ 1996, 312:71-72.
15. OA Nation 2004. Available at:, Accessed March 30, 2010. http://www.arthritiscare.org.uk/PublicationsandResources/Forhealthprofessionals/OANation.
16. Sanders C., Donovan J.L., Dieppe P. Unmet need for joint replacement: a qualitative investigation of barriers to treatment among individuals with severe pain and disability of the hip and knee. Rheumatology 2004, 43:353-357.
17. DeHaan M.N., Guzman J., Bayley M.T., et al. Knee osteoarthritis clinical practice Guidelines. How are we doing?. J Rheumatol 2007, 34:2099-2105.
18. Thorstensson C.A., Gooberman-Hill R., Adamson J., et al. Help-seeking behaviour among people living with chronic hip or knee pain in the community. BMC Musculoskelet Disord 2010, 10:153.
19. Angell M. The truth about drug companies: how they deceive us and what to do about it 2004, Random House, New York.
20. Dieppe P. Evidence-based medicine or medicines-based evidence?. Ann Rheum Dis 1998, 57:385-386.
21. Sterne J.A., Gavaghan D., Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000, 53:1119-1129.
22. Harbord R., Egger M., Sterne J. A modified test for small-study effects in meta-analysis of controlled trials with binary endpoints. Stat Med 2006, 25:3443-3457.
23. Tallon D., Chard J., Dieppe P. Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care Res 2000, 13:312-319.
24. Chard J., Tallon D., Dieppe P. Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Ann Rheum Dis 2000, 59:414-418.
25. Tallon D., Chard J., Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000, 355:2037-2040.
26. Chard J., Dieppe P. Glucosamine for osteoarthritis: magic, hype, or confusion?. BMJ 2001, 322:1439-1440.
27. Vlad S.C., La Valley M.P., McAlindon T.E., et al. Glucosamine for pain in osteoarthritis. Why do trial results differ?. Arthritis Rheum 2007, 56:2267-2277.
28. Doherty M., Dougados M. Evidence-based management of osteoarthritis: practical issues relating to the data. Best Pract Res Clin Rheumatol 2001, 15(4):517-525. Bailliere.
29. Bartlett C., Doyal L., Ebrahim S., et al. The causes and effects of socio-demographic exclusions from clinical trails. Health Technol Assess 2005, 38:1-152.
30. Craig P., Dieppe P., Macintyre S., et al. Developing and evaluating complex interventions: the new MRC guidance. BMJ 2008, 337:1665.
31. Charlton B., Miles A. The rise and fall of EBM. QJM 1998, 91:371-374.
32. Christiansen C., Lou J.Q. Ethical considerations related to evidence-based practice. Am J Occup Ther 2001, 55:345-349.
33. Dieppe P., Szebenyi B. Evidence based rheumatology. J Rheumatol 2000, 27:4-7.
34. Reichenbach S., Sterchi R., Scherer M., et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007, 146:580-590.
35. McAlindon T.E., LaValley M.P., Gulin J.P., et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000, 283:1469-1475.
36. Towheed TE., Maxwell L., Anastassiades TP., et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Library 2005, 2. CD002946.
37. Richy F., Bruyere O., Ethgen O., et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003, 163:1514-1522.
38. Dieppe P., Bartlett C., Davey P., et al. Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs. BMJ 2004, 329:458-459.
39. 'QOF' (Quailty and Outcomes Framework) system Department of Health, 2004 (updated 2009). Available at:, Accessed March 30, 2010. http://www.dh.gov.uk/en/Healthcare/Primarycare/Primarycarecontracting/QOF.
40. Chard J. Investigation of services for osteoarthritis. PhD Thesis, University of Bristol, 2005.
41. Woolf A.D., Walsh N.E., Akesson K. Global core recommendations for a musculoskeletal undergraduate curriculum. Ann Rheum Dis 2004, 63:517-524.
42. Rheumatology 2008, Mosby Elsevier, London (UK). 4th edition. M.C. Hochberg, A.J. Silman, J.S. Smolen (Eds.).
43. 2004, Oxford Textbook of Rheumatology, Oxford University Press, Oxford. P.J. Maddison, P. Woo, D. Isenberg (Eds.).
44. Boyd C.M., Darer J., Boult C., et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid disease. JAMA 2005, 294:716-724.
45. Boyd C., Ritchie C., Tipton E., et al. From bedside to bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Co-morbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res 2008, 20:181-188.
46. Goodrich J., Cornwell J. Seeing the person in the patient 2008, King's Fund, London.
47. Dieppe P., Rafferty A., Kitson A. The clinical encounter-the focal point of patient-centred care. Health Expect 2002, 5:279-281.
48. Zhang W., Robertson J., Jones A., et al. The placebo response and its determinants in osteoarthritis-meta-analysis of randomised controlled trials. Ann Rheum Dis 2008, 67:1716-1723.
49. Doherty M., Dieppe P.A. The " placebo" response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage 2009, 17:1255-1262.
50. Moerman D.E., Jonas W.B. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002, 136:471-476.
51. Kleinman A. The illness narratives: suffering, healing and the human condition 1988, Basic Books (Harper Collins), London.
52. Engel G.L. The need for a new medical model: a challenge for biomedicine. Science 1977, 196:129-136.
53. Jordan K.M., Sawyer S., Coakley P., et al. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology 2004, 43:381-384.
54. Dieppe P. From protocols to principles, from guidelines to toolboxes: aids to the good management of osteoarthritis. Rheumatology 2001, 40:841-842.